Quantifying benefit and harm of extracorporeal life support in cardiogenic shock complicating acute myocardial infarction
- PMID: 39196337
- PMCID: PMC11541401
- DOI: 10.1007/s00134-024-07607-0
Quantifying benefit and harm of extracorporeal life support in cardiogenic shock complicating acute myocardial infarction
Conflict of interest statement
The authors declare that they have no conflicts of interest related to this work.
Figures

References
-
- Thiele H, Akin I, Sandri M et al (2018) One-year outcomes after PCI strategies in cardiogenic shock. N Engl J Med 379:1699–1710 - PubMed
-
- Ughetto A, Schrage B, Delmas C (2024) Cardiogenic shock in 2024: insight the complex reality of ECLS and left ventricular unloading strategies. Intensive Care Med. 10.1007/s00134-024-07400-z - PubMed
-
- Thiele H, Zeymer U, Akin I et al (2023) Extracorporeal life support in infarct-related cardiogenic shock. N Engl J Med 389:1286–1297 - PubMed
-
- Wijeysundera DN, Austin PC, Hux JE et al (2009) Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials. J Clin Epidemiol 62:13-21.e5 - PubMed
Publication types
LinkOut - more resources
Full Text Sources